Thursday Debut
Advanced Accelerator Applications S.A. (Nasdaq: AAAP) – The deal has been postponed due to management’s decision not to proceed with valuation
AltheaDx, Inc (Nasdaq: IDGX)– The underwriter states that this deal will now price Thursday night (2/5) in anticipation of a Friday (2/6) debut.
Asante Solutions, Inc. (Nasdaq: PUMP) – The underwriter states this deal did not price on Wednesday and “there is no timing” currently for the deal. The status of this IPO is now considered to be ‘Day-to-Day’.
Carbylan Therapeutics (Nasdaq: CBYL) – The underwriter states that the deal did not price last night. We are now classifying this IPO as ‘Day-to-Day’. There is no further information at this time.
Inotek Pharmaceuticals Corporation (Nasdaq: ITEK) – The underwriter states that the deal did not price last night and is to be considered ‘day-to-day’. There is no further information at this time.
Nexvet Biopharma plc (Nasdaq: NVET) – The deal priced $3.00 below the prevailing $13-$16 range. ‘NVET’ priced 4 million shares at $10.00 and will debut on Thursday.
IPO Schedule for Remainder of Week
Day to Day
Infraredx (Nasdaq: REDX)
Week of Feb. 2nd
Eyegate Pharmaceuticals (Nasdaq: EYEG)
Friday
AltheaDx, Inc (Nasdaq: IDGX)
Check-Cap Ltd (Nasdaq: CHEK)
Columbia Pipeline Partners LP (NYSE: CPPL)
Easterly Government Properties (NYSE: DEA)
Subscribe now to get our full research report, IPO summary and senior managing partner Scott Sweet’s ratings for this week. There are weekly, monthly and annual plans available.